• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝纤维化与慢性乙型和丙型肝炎患者外周血小板计数减少有关。

Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C.

作者信息

Karasu Zeki, Tekin Fatih, Ersoz Galip, Gunsar Fulya, Batur Yucel, Ilter Tankut, Akarca Ulus S

机构信息

Department of Gastroenterology, Ege University Medical School, Izmir, Turkey.

出版信息

Dig Dis Sci. 2007 Jun;52(6):1535-9. doi: 10.1007/s10620-006-9144-y. Epub 2007 Apr 27.

DOI:10.1007/s10620-006-9144-y
PMID:17464564
Abstract

Thrombocytopenia is a common complication of chronic liver diseases, but its pathogenesis is not clear. Although generally attributed to hypersplenism, other factors should also be considered. We investigated the relationship between the peripheral platelet count and the degree of fibrosis in patients with chronic viral hepatitis. In an effort to avoid the effects of hypersplenism, we excluded patients with splenomegaly and/or bi- or pan-cytopenia. Seven hundred eighty-four patients (265 chronic viral hepatitis C and 519 chronic viral hepatitis B) were included in the study. Univariate analysis showed that the peripheral platelet count had a negative correlation with fibrosis score, necroinflammatory activity, and age in both groups. In multivariate analysis, the peripheral platelet count had a similar correlation with the fibrosis score and age, but not with necroinflammatory activity, in both groups. The peripheral platelet count decreased more significantly in females with chronic hepatitis C but not in the chronic hepatitis B group. In conclusion, a decrease in peripheral platelet count may be a sign of an increase in the degree of fibrosis during the course of chronic viral hepatitis B and C and factors other than hypersplenism may play a role in this decrease in the peripheral platelet count.

摘要

血小板减少症是慢性肝病的常见并发症,但其发病机制尚不清楚。虽然通常归因于脾功能亢进,但也应考虑其他因素。我们研究了慢性病毒性肝炎患者外周血小板计数与纤维化程度之间的关系。为避免脾功能亢进的影响,我们排除了脾肿大和/或全血细胞减少或两系血细胞减少的患者。784例患者(265例慢性丙型病毒性肝炎和519例慢性乙型病毒性肝炎)纳入本研究。单因素分析显示,两组患者外周血小板计数与纤维化评分、坏死性炎症活动及年龄均呈负相关。多因素分析显示,两组患者外周血小板计数与纤维化评分及年龄的相关性相似,但与坏死性炎症活动无关。慢性丙型肝炎女性患者外周血小板计数下降更为显著,而慢性乙型肝炎组则不然。总之,外周血小板计数下降可能是慢性乙型和丙型病毒性肝炎病程中纤维化程度增加的一个迹象,脾功能亢进以外的因素可能在这种外周血小板计数下降中起作用。

相似文献

1
Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C.肝纤维化与慢性乙型和丙型肝炎患者外周血小板计数减少有关。
Dig Dis Sci. 2007 Jun;52(6):1535-9. doi: 10.1007/s10620-006-9144-y. Epub 2007 Apr 27.
2
[Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].慢性乙型和丙型肝炎患者的淋巴细胞亚群、干扰素水平及其受体表达:与病毒种类和肝纤维化程度的相关性
Ter Arkh. 2017;89(11):14-20. doi: 10.17116/terarkh2017891114-20.
3
Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.简单的非侵入性标志物作为慢性丙型肝炎患者纤维化和病毒反应的预测指标。
Turk J Gastroenterol. 2012;23(5):538-45. doi: 10.4318/tjg.2012.0358.
4
A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.一种用于预测慢性病毒性肝炎患者肝硬化的实用评分系统。
Hepatogastroenterology. 2012 Nov-Dec;59(120):2592-7. doi: 10.5754/hge10157.
5
AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.谷草转氨酶/谷丙转氨酶比值在预测慢性病毒性肝炎患者的纤维化程度方面并无用处。
Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1361-6. doi: 10.1097/MEG.0000000000000468.
6
Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients.红细胞分布宽度与血小板比值,慢性肝炎患者肝纤维化的有用指标。
Hepatol Int. 2015 Jul;9(3):454-60. doi: 10.1007/s12072-015-9638-9. Epub 2015 Jun 9.
7
Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease.与其他慢性肝病病因相比,乙肝/丙肝感染患者的血小板生成素血清水平升高。
Liver. 2002 Apr;22(2):114-20. doi: 10.1034/j.1600-0676.2002.01547.x.
8
The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis.血清生物标志物在预测慢性病毒性肝炎患者肝纤维化中的性能
Korean J Gastroenterol. 2017 May 25;69(5):298-307. doi: 10.4166/kjg.2017.69.5.298.
9
Platelet activation in patients with chronic hepatitis C.慢性丙型肝炎患者的血小板活化
Tokai J Exp Clin Med. 2002 Dec;27(4):101-6.
10
The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B.血小板计数在评估慢性乙型肝炎患者肝纤维化程度中的价值。
J Clin Lab Anal. 2020 Jul;34(7):e23270. doi: 10.1002/jcla.23270. Epub 2020 May 4.

引用本文的文献

1
Neutrophil-derived ratios as predictors of short-term mortality in HBV-associated decompensated cirrhosis.中性粒细胞衍生比率作为乙肝相关失代偿期肝硬化短期死亡率的预测指标
BMC Gastroenterol. 2025 May 26;25(1):404. doi: 10.1186/s12876-025-03991-z.
2
Prognostic Value of Platelet-to-Monocyte Ratio for Mortality in HBV-Related Acute-on-Chronic Liver Failure.血小板与单核细胞比值对乙肝相关慢加急性肝衰竭患者死亡率的预后价值
Int J Gen Med. 2024 Jul 18;17:3173-3180. doi: 10.2147/IJGM.S464402. eCollection 2024.
3
Viruses and thrombocytopenia.病毒与血小板减少症

本文引用的文献

1
The pathogenesis of splenomegaly in hypertension of the portal circulation; congestive splenomegaly.门脉循环性高血压中脾肿大的发病机制;充血性脾肿大。
Medicine (Baltimore). 1948 May;27(2):187-221.
2
Portal hypertension, congestive splenomegaly, and portacaval shunt.门静脉高压、充血性脾肿大和门腔分流术。
Gastroenterology. 1962 May;42:555-9.
3
Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block.
Heliyon. 2024 Mar 16;10(6):e27844. doi: 10.1016/j.heliyon.2024.e27844. eCollection 2024 Mar 30.
4
Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017-2020.血小板/高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病的关系:来自 NHANES 2017-2020 的结果。
Lipids Health Dis. 2023 Aug 11;22(1):130. doi: 10.1186/s12944-023-01861-9.
5
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients.长期抗病毒治疗会降低慢性乙型肝炎患者肝细胞癌预测模型的性能。
Clin Mol Hepatol. 2023 Jul;29(3):747-762. doi: 10.3350/cmh.2023.0121. Epub 2023 May 10.
6
Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection.乙型肝炎病毒和丙型肝炎病毒感染患者血小板减少症相关常见危险因素的不同影响。
Biomed J. 2022 Oct;45(5):788-797. doi: 10.1016/j.bj.2021.09.001. Epub 2021 Sep 8.
7
Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease.直接抗病毒治疗对丙型肝炎病毒相关慢性肝病血小板减少患者的影响。
Gastroenterol Res Pract. 2021 May 23;2021:8811203. doi: 10.1155/2021/8811203. eCollection 2021.
8
FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience.丙型肝炎感染患者接受直接抗病毒治疗时的FIB-4回归:一家安全网医院的经验
Front Med (Lausanne). 2020 Jul 22;7:359. doi: 10.3389/fmed.2020.00359. eCollection 2020.
9
Dynamic Differences Of Red Cell Distribution Width Levels Contribute To The Differential Diagnosis Of Hepatitis B Virus-related Chronic Liver Diseases: A Case-control Study.红细胞分布宽度水平的动态差异有助于乙型肝炎病毒相关慢性肝病的鉴别诊断:一项病例对照研究。
Int J Med Sci. 2019 May 10;16(5):720-728. doi: 10.7150/ijms.31826. eCollection 2019.
10
Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.比较不同评分系统在肝癌治疗方式中的总体生存预测价值:以血小板-白蛋白-胆红素(PALBI)和白蛋白-胆红素(ALBI)分级为重点:一项全国性队列研究。
PLoS One. 2019 May 2;14(5):e0216173. doi: 10.1371/journal.pone.0216173. eCollection 2019.
Am J Gastroenterol. 1959 Sep;32:291-310.
4
The effect of portacaval shunt on thrombocytopenia associated with portal hypertension.门腔分流术对门静脉高压症相关血小板减少症的影响。
Ann Intern Med. 1961 Oct;55:598-603. doi: 10.7326/0003-4819-55-4-598.
5
Peripheral blood picture after operation for portal hypertension.门静脉高压症手术后的外周血象
Lancet. 1953 Jun 6;1(6771):1120-3. doi: 10.1016/s0140-6736(53)92308-3.
6
Platelet activation in patients with chronic hepatitis C.慢性丙型肝炎患者的血小板活化
Tokai J Exp Clin Med. 2002 Dec;27(4):101-6.
7
Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma.慢性病毒性肝炎和肝细胞癌患者血清及肝组织中的血小板生成素水平
Clin Sci (Lond). 2000 Sep;99(3):207-14.
8
Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.血清转氨酶水平和血小板计数作为慢性丙型肝炎病毒感染纤维化程度的预测指标。
Am J Gastroenterol. 2001 Nov;96(11):3142-6. doi: 10.1111/j.1572-0241.2001.05268.x.
9
Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C--a study of 527 patients at one establishment.
J Viral Hepat. 2000 Jul;7(4):268-75. doi: 10.1046/j.1365-2893.2000.00235.x.
10
Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis.血小板生成素表达降低与人类和大鼠肝硬化中的血小板减少有关。
J Gastroenterol Hepatol. 1998 Sep;13(9):907-13. doi: 10.1111/j.1440-1746.1998.tb00760.x.